Cross-cluster projects

Cross-cluster project AI & Biotechnology


The ongoing development of artificial intelligence (AI) and large language models (LLM) has great potential for application in biotechnology.

For example, AI algorithms analyse huge biological data sets, simulate interactions and enable the personalised adaptation of treatment plans. The fields of application of AI in red biotechnology are numerous, but the potentially revolutionary transformation offers both opportunities and challenges for biotechnology companies.

The cross-cluster project of BioM Biotech Cluster Development and the Bavarian AI Agency aimed to support Bavarian companies in the application of AI, to develop key topics, concrete examples and guidance, and to connect companies, experts and stakeholders in the biotechnology cluster and AI network.

Partner: Bavarian AI Agency

Acitvities:

  • BayOConnect (July 2024): Exchange format for networking with experts on regulatory & legal issues, demonstration of an AI-supported tool for regulatory affairs in life sciences
  • Seminar “AI for Innovations in Life Sciences” (October 2024): Presentations on IP management, data analysis and AI practical applications in life sciences
  • Digital Health Summit (November 2024): Exchange format for discussing digital innovations and networking between industry players
  • Online event “Adapting to the AI Act” (December 2024): Information and discussion on regulatory requirements of the European AI Act and practical experience report on the application of AI in RNA analyses and dealing with regulatory requirements

Duration: 1 year (2024)

Contact persons:
Ariane Doischer (doischer@bio-m.org)
Sabine Cornils (cornils@remove-this.ai-agency.de)

Ariane Doischer
Ariane Doischer

International Relations




Cross-cluster project biotechnology & nanotechnology


In recent decades, the research and development fields of biotechnology and nanotechnology have each developed enormously, moving constantly towards each other and forming increasingly large intersections.

The integration of innovative and disruptive technologies is increasingly being used at the interface between the two fields, including digitization and quantum technologies.

The collaboration between nanotechnology and biotechnology has the potential to create significant long-term value for Bavaria and added value for companies due to the expertise already available. This enables the (further) development of high-precision diagnostic and therapeutic approaches, even in the field of prevention.

The aim of the cross-cluster project of the biotechnology and nanotechnology clusters was to link the competencies within the individual clusters more closely and to make sustainable use of them. 

At the beginning, the needs of both sectors were determined and interfaces identified. During two intensive workshops, several topics were identified as highly relevant, particularly in the areas of analytics, AI use, up-scaling, process optimization, drug delivery and regulation.

In addition, the first collaboration projects have already emerged as a result of the events.

In order to consolidate the exchange that has already begun as effectively as possible, BioM will apply for funding for a ZIM cooperation network in collaboration with the nanotechnology cluster. The network aims to offer small and medium-sized enterprises (SMEs) and academic research institutions from both sectors a platform for exchange and to promote the joint implementation of research and development projects.  

Partner: Cluster Nanotechnology

Duration: 1 year (2024)

Contact persons:
Dr. Max Pöhlmann (poehlmann@remove-this.bio-m.org)
Dr. Peter Grambow (peter.grambow@nanoinitiative-bayern.de)
Dr. Justus Hermannsdörfer (justus.hermannsdoerfer@remove-this.nanoinitiative-bayern.de)


The cross-cluster projects are funded by the Bavarian State Ministry of Economic Affairs, Regional Development and Energy as part of the Bavarian Cluster Initiative. Cross-cluster projects are intended to initiate innovations at the interfaces between networks: Several clusters or networks join forces to pool the innovative power of their players from business and research for a specific project.

Dr. Max Pöhlmann
Dr. Max Pöhlmann

Cluster Development Lead